Centocor Research and Development, Inc., Radnor, PA 19087, USA.
Biopolymers. 2010;94(3):350-9. doi: 10.1002/bip.21390.
The protein human CC chemokine ligand 2 (CCL2, also known as monocyte chemoattractant protein 1 or MCP-1) has been synthesized using a combination of solid phase peptide synthesis (SPPS) and native chemical ligation (NCL). The thioester-peptide segment was synthesized using the sulfonamide safety-catch linker and 9-fluorenylmethoxycarbonyl (Fmoc) SPPS, and pseudoproline dipeptides were used to facilitate the synthesis of both CCL2 fragments. After assembly of the full-length peptide chain by NCL, a glutathione redox buffer was used to fold and oxidize the CCL2 protein. Synthetic human CCL2 binds to and activates the CCR2 receptor on THP-1 cells, as expected. CCL2 was crystallized and the structure was determined by X-ray diffraction at 1.9-A resolution. The structure of the synthetic protein is very similar to that of a previously reported structure of recombinant human CCL2, although the crystal form is different. The functional CCL2 dimer for the crystal structure reported here is formed around a crystallographic twofold axis. The dimer interface involves residues Val9-Thr10-Cys11, which form an intersubunit antiparallel beta-sheet. Comparison of the CCL2 dimers in different crystal forms indicates a significant flexibility of the quaternary structure. To our knowledge, this is one of the first crystal structures of a protein prepared using the sulfonamide safety-catch linker and NCL.
人蛋白 CC 趋化因子配体 2(CCL2,也称为单核细胞趋化蛋白 1 或 MCP-1)已使用固相肽合成(SPPS)和天然化学连接(NCL)的组合进行合成。硫酯肽段使用磺酰胺安全捕获接头和 9-芴甲氧羰基(Fmoc)SPPS 合成,并且使用拟肽二肽来促进 CCL2 片段的合成。通过 NCL 组装全长肽链后,使用谷胱甘肽氧化还原缓冲液折叠和氧化 CCL2 蛋白。合成的人 CCL2 与 THP-1 细胞上的 CCR2 受体结合并激活该受体,正如预期的那样。CCL2 被结晶,并且结构通过 X 射线衍射在 1.9-A 分辨率下确定。该合成蛋白的结构与先前报道的重组人 CCL2 的结构非常相似,尽管晶体形式不同。报告的晶体结构的功能性 CCL2 二聚体是围绕晶体学二倍轴形成的。二聚体界面涉及残基 Val9-Thr10-Cys11,其形成亚基间的反平行 β-折叠。不同晶体形式的 CCL2 二聚体的比较表明四级结构具有很大的灵活性。据我们所知,这是使用磺酰胺安全捕获接头和 NCL 制备的蛋白质的第一个晶体结构之一。